Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Nishank Jain

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Jain, Nishank

PropertyValue
overview Nishank Jain, MD, MPH, is a nephrologist and an Associate Professor in the Department of Medicine at University of Arkansas for Medical Sciences, Little Rock, AR. He completed his clinical and research fellowship at UT Southwestern Medical Center, Dallas, TX, before joining as a faculty member. His research interest is in the role of platelets in CKD pathophysiology and use of antiplatelet agents in patients with kidney diseases. He has been funded by post-doctoral fellowship grant from the American Heart Association (AHA), institutional KL2 grant and career development grants from the American Society of Nephrology and the AHA. Dr. Jain is passionate about education and is driven by training and engaging medical students for a career in academic medicine. He has also helped medical students receive Honors in Research upon graduation. Dr. Jain has received medical student teaching awards. He has also engaged in SSCI activities by sending medical students to present original research work at the Annual Meetings.

One or more keywords matched the following items that are connected to Jain, Nishank

Item TypeName
Academic Article Antiplatelet therapy in the management of cardiovascular disease in patients with CKD: what is the evidence?
Academic Article How should clinicians interpret cardiac troponin values in patients with ESRD?
Academic Article Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.
Academic Article Are calcium-based phosphate binders ever preferable in dialysis patients?
Academic Article Differences in Whole Blood Platelet Aggregation at Baseline and in Response to Aspirin and Aspirin Plus Clopidogrel in Patients With Versus Without Chronic Kidney Disease.
Academic Article Predictors of hyperkalemia and death in patients with cardiac and renal disease.
Academic Article Oral P2Y12 Receptor Inhibitors in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions: Current?Knowledge and Future Directions.
Academic Article Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
Academic Article Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease.
Grant Effectiveness and safety of clopidogrel, prasugrel and ticagrelor in patients with end stage renal disease (ESCALATE)
Academic Article Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial.
Academic Article Trends for and Clinical Factors Associated with Choice of Oral P2Y12 Inhibitors for Patients on Chronic Dialysis.
Grant Study of uremic toxins and levels of antiplatelet therapy to investigate mechanisms of excessive stroke in patients with chronic kidney disease
Grant A Mechanistic Study in Patients with Non-Dialysis Chronic Kidney Disease to Investigate Altered Platelet Response to Antiplatelet Therapy (CKD-Platelet Study)
Academic Article Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis.
Academic Article Potent Antiplatelet Therapy May Reduce Death from Sepsis in Patients on Chronic Dialysis.
Academic Article Accurate Medication Adherence Measurement Using Administrative Data for Frequently Hospitalized Patients.
Academic Article Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study.
Academic Article Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease.
Grant Platelet-Leukocyte Axis in Patients with Chronic Kidney Disease
Academic Article Age Modifies Intracranial and Gastrointestinal Bleeding Risk from P2Y12 Inhibitors in Patients Receiving Dialysis.
Academic Article Platelet Count and Platelet Volume in Patients with CKD.
Grant Platelet-Leukocyte Axis in Patients with Chronic Kidney Disease
Grant Platelet-Leukocyte Axis in Patients with Chronic Kidney Disease
Grant Platelet-Leukocyte Axis in Patients with Chronic Kidney Disease
Grant Platelet-Leukocyte Axis in Patients with Chronic Kidney Disease
Academic Article Updates on New Therapies for Patients with CKD.

Search Criteria
  • Outpatients